Merck (MRK) FCF Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,396.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-935.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
1,326.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
1,043.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
511.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,008.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
934.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-853.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,043.00 |
| Dec 31, 2025 |
-496.00 |
| Sep 30, 2025 |
-1,151.00 |
| Jun 30, 2025 |
-1,408.00 |
| Mar 31, 2025 |
-658.00 |
| Dec 31, 2024 |
2,116.00 |
| Sep 30, 2024 |
838.00 |
| Jun 30, 2024 |
1,186.00 |
| Mar 31, 2024 |
1,184.00 |
| Dec 31, 2023 |
-2,880.00 |
| Sep 30, 2023 |
1,277.00 |
| Jun 30, 2023 |
-353.00 |
| Mar 31, 2023 |
-2,146.00 |
| Dec 31, 2022 |
-502.00 |
| Sep 30, 2022 |
236.00 |
| Jun 30, 2022 |
1,294.00 |
| Mar 31, 2022 |
2,227.00 |
| Dec 31, 2021 |
1,067.00 |
| Sep 30, 2021 |
1,585.00 |
| Jun 30, 2021 |
-564.00 |
| Mar 31, 2021 |
380.00 |
| Dec 31, 2020 |
3,724.00 |
| Sep 30, 2020 |
-1,464.00 |
| Jun 30, 2020 |
-513.00 |
| Mar 31, 2020 |
-916.00 |
| Dec 31, 2019 |
-4,337.00 |
| Sep 30, 2019 |
653.00 |
| Jun 30, 2019 |
-717.00 |
| Mar 31, 2019 |
-17.00 |
| Dec 31, 2018 |
-746.00 |
| Sep 30, 2018 |
3,544.00 |
| Jun 30, 2018 |
-270.00 |
| Mar 31, 2018 |
759.00 |
| Dec 31, 2017 |
121.00 |
| Sep 30, 2017 |
-3,993.00 |
| Jun 30, 2017 |
1,700.00 |
| Mar 31, 2017 |
-2,090.00 |
| Dec 31, 2016 |
-628.00 |
| Sep 30, 2016 |
-542.00 |
| Jun 30, 2016 |
-1,235.00 |
| Mar 31, 2016 |
-174.00 |
| Dec 31, 2015 |
5,129.00 |
| Sep 30, 2015 |
-842.00 |
| Jun 30, 2015 |
638.00 |
| Mar 31, 2015 |
107.00 |
| Dec 31, 2014 |
-3,749.00 |
| Sep 30, 2014 |
558.00 |
| Jun 30, 2014 |
93.00 |
| Mar 31, 2014 |
236.00 |
| Dec 31, 2013 |
1,416.00 |
| Sep 30, 2013 |
886.00 |
| Jun 30, 2013 |
-273.00 |
| Mar 31, 2013 |
311.00 |
| Dec 31, 2012 |
-1,261.00 |
| Sep 30, 2012 |
-1,077.00 |
| Jun 30, 2012 |
-25.00 |
| Mar 31, 2012 |
348.00 |
| Dec 31, 2011 |
-241.00 |
| Sep 30, 2011 |
1,423.00 |
| Jun 30, 2011 |
-587.00 |
| Mar 31, 2011 |
311.00 |
| Dec 31, 2010 |
711.00 |
| Sep 30, 2010 |
3,043.00 |
| Jun 30, 2010 |
1,983.00 |
| Mar 31, 2010 |
9.00 |
